Cairo – Mubasher: The financial statements of Sabaa International Company for Pharmaceutical and Chemical Industry showed an 84% year-on-year decline in the company's profits during the first nine months of the current year.
According to the company's financial statements submitted to the Egyptian Exchange (EGX), the company recorded a net profit after tax of EGP 2.67 million during the period from January to the end of September 2026, compared to EGP 16.734 million in the corresponding period of 2025.
In terms of revenues, the company's sales reached approximately EGP 27,806 by the end of September 2026, compared to EGP 41,967 in the same period of the previous year.
